Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for DV Biomed Co., Ltd. (6539:TWSE), powered by AI.
DV Biomed Co., Ltd. is currently trading at $40.95. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for DV Biomed Co., Ltd. on Alpha Lenz.
View DV Biomed Co., Ltd.'s valuation metrics on Alpha Lenz.
“DV Biomed Co., Ltd.'s ROE is 1.5%. Explore profitability and growth together.”
Ask for details →DV Biomed Co., Ltd. is a biotechnology and healthcare company specializing in the manufacture and distribution of medical-grade skin care products and health-related solutions. Founded in 2011 and headquartered in Taipei, the company operates primarily in the healthcare and biotechnology sectors, with activities extending across Taiwan and China. DV Biomed’s offerings encompass a range of skin care products, health and slimming services, and medical aesthetic fillers, along with aesthetic medical equipment for use in medical beauty industries. The company is also involved in the research and development of stem cell technologies, genomics, anti-cancer drugs, and proteomics, reflecting a commitment to innovative therapies and advanced health solutions. In addition to these specialized products and services, DV Biomed provides functional beverages and nutritional supplements targeting beauty, wellness, and slimming markets. With a diverse portfolio spanning medical consumables, beauty equipment rentals, and services in both clinical and consumer spheres, DV Biomed Co., Ltd. plays a significant role in supporting health, wellness, and cosmetic advancements throughout the region.
“DV Biomed Co., Ltd.'s ROE is 1.5%. Explore profitability and growth together.”
Ask for details →DV Biomed Co., Ltd. (ticker: 6539) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
The current price is 40.95 with a P/E ratio of -x and P/B of -x.
ROE is 1.49% and operating margin is 1.88%. Annual revenue is $794M.